An official website of the United States government
          Here’s how you know
        Here’s how you know**Official websites use .gov**A
              **.gov** website belongs to an official government
              organization in the United States.
        **Secure .gov websites use HTTPS**A
              **lock** (
              Locked padlock icon) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
 Top Utility Nav
        
        
        Asian-Language Resources
        
        Portal en español


Site search Mega Menu
  

        

        Home
                  Health Topics
                                      
    
  Health Topics

    Arthritis and Rheumatic Diseases
          
    Muscle and Bone Diseases
          
    Skin Diseases
          
    All Diseases and Conditions
          
    Publication Catalog
                  Grants & Funding
                                      
    
  Grants & Funding

    Current Funding Opportunities
          
    Supported Scientific Programs
          
    NIAMS-Supported Programs
          
    Applying for a Grant
          
    NIH Policies and Guidance
          
    Peer Review and Grants Administration Resources
          
    Types of Funding Mechanisms (Activity Codes)
                  Labs @ NIAMS
                                      
    
  Labs @ NIAMS

    NIAMS Labs and Core Facilities
          
    Research Faculty
          
    Research Areas
          
    NIAMS Scientific Advances
          
    Training and Career Development
                  Clinical Trials
                                      
    
  Clinical Trials
      
            For Principal Investigators

    Clinical Trial Policies, Guidelines, and Templates
          
    Conducting Clinical Trials
          
    Register with ClinicalTrials.gov

For Patients

What is a Clinical Trial?
	Clinical Trials at NIAMS
	Clinical Trials in the Spotlight
                  News & Events
                                      
    
  Newsroom

    All NIAMS News
          
    NIAMS Newsletters
          
    Meetings & Events
                  About NIAMS
                                      
    
  About NIAMS

    Director's Page
          
    NIAMS Organization
          
    Strategic Plan Fiscal Years 2020-2024
          
    Staff Directory
          
    NIAMS Budget
          
    Partnerships
          
    Contact NIAMS
                  Community Outreach
                                      
    
  Community Outreach

    Bone Health
          
    Joint Health
          
    Muscle, Tendon, and Ligament Health
          
    Skin Health
          
    Health Information For Kids And Young Adults
          
    Health Information For Older Adults/Seniors
          
    Printable Materials for Community Events
          
    Resources in Other Languages
          
    Annual Health Observances
          
    Social Media Resources Breadcrumb
    Home
          Grants & Funding: The NIAMS Extramural Program
          Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19)








Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19) FacebookEmailPrintFacebookEmail     
    PEPR Overview

The Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19) will capitalize on recent advances in the science of Patient Reported Outcomes (PROs) to assess the health of children with a variety of chronic diseases and conditions in clinical research and care settings.

Examples of chronic diseases or conditions in children include (but are not limited to): asthma, juvenile arthritis, cystic fibrosis, diabetes, obesity and overweight, chronic kidney disease, inflammatory bowel disease, sickle cell disease, malnutrition, developmental disabilities including attention deficit/hyperactivity disorder and autism spectrum disorder, cerebral palsy and mental illnesses.

Many of these diseases and conditions cause patients to have pain or experience fatigue; affect their sleep; alter their ability to physically or mentally function on a daily basis; or in other ways interfere with their social relationships and overall quality-of-life. The impact, importance, and value of pediatric self-reporting (and parent-proxy reporting) in the evaluation of treatment efficacy and effectiveness support the need for a universally applicable, common metric in order to allow clinically meaningful comparisons of treatments of disease, both within and across chronic pediatric diseases and conditions.

The PEPR Consortium will feature the utilization of the Patient Reported Outcomes Measurement Information System (PROMIS®) pediatric self-report and parent proxy instruments. These instruments include those already, or soon to be, available at the Assessment Center.

PEPR Consortium Goals

The main, long-term goal of the Consortium is to conduct robust clinical validation studies of child patient-reported outcomes (cPROs) in clinical trials and care settings, and to examine the impact of environmental stressors (including socioeconomic aspects) on children’s symptoms and quality of life in a variety of chronic diseases or conditions. Therefore, cPROs may advance personalized, precision medicine by coupling with detailed clinical phenotyping and/or biospecimen collections in established, well-characterized pediatric cohorts. Development of new domains that extend the measurement science of cPROs to address environmental stressors/exposures, and that fit into the PROMIS domain framework following PROMIS standards, is also possible. Successful applicants will be recognized leaders in clinical pediatric research and patient care with demonstrated expertise in leading large clinical collaborative projects, as well as recruiting and retaining cohort(s) of high quality.

PEPR Structure

The figure below highlights key features of the structure of the proposed Consortium. Details are included in the FOA.
Consortium structure flowchart. Research Programs A, B, and C at three corners of a triangle with a Data Portal in the center. PEPR Contacts

For NIAMS contacts listed in the FOA, please submit questions to PEPR@mail.nih.gov. In addition to the NIAMS contacts listed in the FOA, the following NIH Institutes are participating in this initiative and the individuals below may be contacted for questions or more information.

Lynne Haverkos, M.D., M.P.H.*Eunice Kennedy Shriver* National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-6881
Email: LH179R@nih.gov

Ellen Werner, Ph.D., M.A.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0050
Email: Ellen.Werner@nih.gov

Marva Moxey-Mims, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-7717
Email: mm726k@nih.gov

Derrick Tabor, Ph.D.
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-8950
Email: Dt103j@nih.gov

Ashley Wilder Smith, Ph.D., M.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-6714
Email: smithas@mail.nih.gov

Ann E. Wagner, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-5944
Email: awagner@mail.nih.gov
    

          Related Information
      
  

      PROMIS Pediatric Banks and PROMIS Parent Proxy Banks

NIAMS-Funded awards


Last Updated: August 2019


Back to Top


About NIAMS
                    Clinical Trials
                    Grants & Funding
                    Health Topics
                    Labs @ NIAMS
              News Room
                    NIAMS Multimedia Library
                    Disclaimer
                    FOIA
                    Contact us
              Privacy Statement
                    Accessibility
                    HHS Vulnerability Disclosure
                    Social Media Moderation Policy
                    NIAMS Archives
 Subscribe to Our E-Newsletters Click the button to see different options to sign up for newsletters. Click Here to Subscribe
 Follow us on


About NIH
                  Accessibility Support
            FOIA requests
                  No FEAR Act data
            Office of the Inspector General
                  Performance reports
            Privacy Policy